Recursion Pharmaceuticals Inc
NASDAQ:RXRX

Watchlist Manager
Recursion Pharmaceuticals Inc Logo
Recursion Pharmaceuticals Inc
NASDAQ:RXRX
Watchlist
Price: 6.03 USD -0.99%
Market Cap: 2.3B USD
Have any thoughts about
Recursion Pharmaceuticals Inc?
Write Note

Cash Flow Statement

Cash Flow Statement
Recursion Pharmaceuticals Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Operating Cash Flow
Net Income
(84)
(186)
(212)
(234)
(247)
(239)
(249)
(260)
(293)
(328)
(354)
(375)
(378)
Depreciation & Amortization
4
8
10
10
11
12
13
15
20
24
28
31
31
Stock-Based Compensation
11
15
19
19
25
28
31
37
45
54
61
66
67
Other Non-Cash Items
12
20
26
29
35
39
44
47
54
66
72
74
84
Cash Interest Paid
(0)
1
0
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
5
(0)
126
117
102
105
(42)
(43)
(40)
(50)
(62)
(62)
(55)
Cash from Operating Activities
(63)
N/A
(159)
-152%
(50)
+68%
(78)
-55%
(100)
-27%
(84)
+16%
(234)
-180%
(240)
-2%
(258)
-8%
(288)
-11%
(317)
-10%
(332)
-5%
(318)
+4%
Investing Cash Flow
Capital Expenditures
(34)
(40)
(25)
(35)
(34)
(37)
(38)
(25)
(18)
(12)
(13)
(11)
(14)
Other Items
(184)
(232)
(84)
(63)
183
230
82
63
2
2
2
(3)
(3)
Cash from Investing Activities
(219)
N/A
(272)
-24%
(109)
+60%
(98)
+10%
149
N/A
193
+30%
45
-77%
38
-16%
(16)
N/A
(10)
+35%
(12)
-13%
(14)
-18%
(18)
-31%
Financing Cash Flow
Net Issuance of Common Stock
463
471
471
10
16
154
154
155
157
141
153
412
427
Net Issuance of Debt
(19)
(13)
(13)
(13)
(0)
(0)
(0)
(0)
50
(1)
(1)
(1)
(53)
Other
5
0
0
0
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
448
N/A
459
+2%
458
0%
(3)
N/A
11
N/A
154
+1 317%
154
0%
155
+1%
207
+33%
140
-32%
152
+9%
411
+170%
374
-9%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
(0)
(0)
(0)
(0)
0
(0)
(0)
0
Net Change in Cash
167
N/A
28
-83%
299
+961%
(179)
N/A
60
N/A
264
+340%
(36)
N/A
(47)
-32%
(68)
-43%
(158)
-133%
(176)
-12%
66
N/A
39
-41%
Free Cash Flow
Free Cash Flow
(97)
N/A
(198)
-105%
(75)
+62%
(113)
-51%
(133)
-18%
(121)
+10%
(272)
-126%
(265)
+2%
(276)
-4%
(300)
-8%
(330)
-10%
(342)
-4%
(332)
+3%

See Also

Discover More